Research ArticleBasic Science Investigations
Comparative Evaluation of 18F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents
Karl Ploessl, Limin Wang, Brian P. Lieberman, Wenchao Qu and Hank F. Kung
Journal of Nuclear Medicine October 2012, 53 (10) 1616-1624; DOI: https://doi.org/10.2967/jnumed.111.101279
Karl Ploessl
1Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania; and
Limin Wang
1Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania; and
Brian P. Lieberman
1Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania; and
Wenchao Qu
1Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania; and
Hank F. Kung
1Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania; and
2Department of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania
In this issue
Journal of Nuclear Medicine
Vol. 53, Issue 10
October 1, 2012
Comparative Evaluation of 18F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents
Karl Ploessl, Limin Wang, Brian P. Lieberman, Wenchao Qu, Hank F. Kung
Journal of Nuclear Medicine Oct 2012, 53 (10) 1616-1624; DOI: 10.2967/jnumed.111.101279
Jump to section
Related Articles
Cited By...
- 18F-Fluciclovine PET Imaging of Glutaminase Inhibition in Breast Cancer Models
- First-in-Human PET Imaging and Estimated Radiation Dosimetry of L-[5-11C]-Glutamine in Patients with Metastatic Colorectal Cancer
- Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer
- Preclinical Applications of Multi-Platform Imaging in Animal Models of Cancer
- Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer
- Glutamate-Weighted Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Detects Glutaminase Inhibition in a Mouse Model of Triple-Negative Breast Cancer
- Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
- Metabolic Imaging of Glutamine in Cancer
- [18F](2S,4R)4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple-Negative Breast Cancer in Response to Glutaminase Inhibition
- Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
- Functional Imaging of Oxidative Stress with a Novel PET Imaging Agent, 18F-5-Fluoro-L-Aminosuberic Acid